DE60005685D1 - Oxazinocarbazole zur behandlung von cns-erkrankungen - Google Patents

Oxazinocarbazole zur behandlung von cns-erkrankungen

Info

Publication number
DE60005685D1
DE60005685D1 DE60005685T DE60005685T DE60005685D1 DE 60005685 D1 DE60005685 D1 DE 60005685D1 DE 60005685 T DE60005685 T DE 60005685T DE 60005685 T DE60005685 T DE 60005685T DE 60005685 D1 DE60005685 D1 DE 60005685D1
Authority
DE
Germany
Prior art keywords
oxazinocarbazole
treatment
cns diseases
cns
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60005685T
Other languages
English (en)
Other versions
DE60005685T2 (de
Inventor
E Tenbrink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of DE60005685D1 publication Critical patent/DE60005685D1/de
Application granted granted Critical
Publication of DE60005685T2 publication Critical patent/DE60005685T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DE60005685T 1999-07-28 2000-07-20 Oxazinocarbazole zur behandlung von cns-erkrankungen Expired - Fee Related DE60005685T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14601399P 1999-07-28 1999-07-28
US146013P 1999-07-28
PCT/US2000/019532 WO2001009142A1 (en) 1999-07-28 2000-07-20 Oxazinocarbazoles for the treatment of cns diseases

Publications (2)

Publication Number Publication Date
DE60005685D1 true DE60005685D1 (de) 2003-11-06
DE60005685T2 DE60005685T2 (de) 2004-08-12

Family

ID=22515535

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60005685T Expired - Fee Related DE60005685T2 (de) 1999-07-28 2000-07-20 Oxazinocarbazole zur behandlung von cns-erkrankungen

Country Status (20)

Country Link
US (2) US6448397B1 (de)
EP (1) EP1200447B1 (de)
JP (1) JP2003506328A (de)
KR (1) KR20020015079A (de)
CN (1) CN1165539C (de)
AR (1) AR024963A1 (de)
AT (1) ATE251167T1 (de)
AU (1) AU767282B2 (de)
BR (1) BR0012791A (de)
CA (1) CA2376927A1 (de)
CO (1) CO5031298A1 (de)
DE (1) DE60005685T2 (de)
DK (1) DK1200447T3 (de)
ES (1) ES2208371T3 (de)
MX (1) MXPA02000984A (de)
PE (1) PE20010548A1 (de)
PT (1) PT1200447E (de)
TW (1) TWI222450B (de)
WO (1) WO2001009142A1 (de)
ZA (1) ZA200110539B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100497122B1 (ko) * 2001-08-30 2005-06-29 주식회사 삼양제넥스 페놀옥시다제 시스템을 구성하는 단백질 및 그것의 유전자
SE0103539D0 (sv) * 2001-10-23 2001-10-23 Biovitrum Ab New Use
DE60232173D1 (de) * 2001-11-09 2009-06-10 Biovitrum Ab Publ Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
US6932961B1 (en) 2002-04-16 2005-08-23 Pharmacia & Upjohn Company Oxazinocarbazoles for the treatment of CNS diseases
AU2003222038A1 (en) * 2002-04-16 2003-11-03 Pharmacia And Upjohn Company Llc Labeled oxazinocarbazoles as diagnostic agents
ES2291722T3 (es) * 2002-12-03 2008-03-01 Hoffmann La Roche Aminoalcoxiindoles como ligandos 5-ht6-receptores para el tratamiento de transtornos del snc.
EP2004659A1 (de) 2006-04-12 2008-12-24 Wyeth Substituierte dihydro[1,4]oxazin[2,3,4-hi]indazol-derivate als 5-hydroxytryptamin-6-liganden

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3885357T2 (de) * 1987-06-29 1994-03-24 Duphar Int Res Anellierte Indolderivate.
GB8812636D0 (en) 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
EP0377238A1 (de) 1988-12-22 1990-07-11 Duphar International Research B.V Annelierte Indolo(3,2-c)-lactame
EP0725068A4 (de) * 1993-10-20 1997-01-22 Tokyo Tanabe Co Indolderivate
TW422837B (en) 1996-05-31 2001-02-21 Mochida Pharm Co Ltd Pyridocarbazole deivatives having cGMP-PDE inhibitory activity

Also Published As

Publication number Publication date
PE20010548A1 (es) 2001-05-13
US6821970B2 (en) 2004-11-23
KR20020015079A (ko) 2002-02-27
AU767282B2 (en) 2003-11-06
DE60005685T2 (de) 2004-08-12
EP1200447A1 (de) 2002-05-02
TWI222450B (en) 2004-10-21
JP2003506328A (ja) 2003-02-18
CN1165539C (zh) 2004-09-08
US20020169317A1 (en) 2002-11-14
MXPA02000984A (es) 2002-07-30
CN1361781A (zh) 2002-07-31
AR024963A1 (es) 2002-10-30
ZA200110539B (en) 2003-03-24
WO2001009142A1 (en) 2001-02-08
ES2208371T3 (es) 2004-06-16
ATE251167T1 (de) 2003-10-15
PT1200447E (pt) 2004-02-27
CO5031298A1 (es) 2001-04-27
BR0012791A (pt) 2002-06-18
CA2376927A1 (en) 2001-02-08
US6448397B1 (en) 2002-09-10
DK1200447T3 (da) 2004-02-02
AU6219700A (en) 2001-02-19
EP1200447B1 (de) 2003-10-01

Similar Documents

Publication Publication Date Title
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE60006412D1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen
ATE285764T1 (de) Rivastigmine zur behandlung von augenerkrankungen
DE60043648D1 (de) Medikamente zur behandlung von periodontalen erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee